Nifty
Sensex
:
:
10579.00
35159.00
-77.20 (-0.72%)
-315.51 (-0.89%)

Pharmaceuticals & Drugs

Rating :
45/99

BSE: 524470 | NSE: Not Listed

1.07
0.01 (0.94%)
21-Nov-2018 | 11:03AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1.06
  •  1.09
  •  1.05
  •  1.06
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  300704
  •  3.22
  •  2.42
  •  0.71

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 82.75
  • 8.54
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 89.00
  • N/A
  • 0.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.98%
  • 3.58%
  • 54.25%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.19%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.67
  • 0.95
  • -4.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.70
  • -6.38
  • -6.84

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.60
  • -1.48
  • -5.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.64
  • 18.90
  • 14.64

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.15
  • 2.54
  • 1.35

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.96
  • 14.32
  • 8.19

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
-
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
-
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
-
102.80
106.54
116.00
101.72
77.54
Gross Profit
-
82.03
77.36
57.40
49.57
37.41
GP Margin
-
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
-
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
-
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
-
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
-
2.79
2.67
1.98
1.12
1.15
Interest
-
0.33
0.14
0.29
0.47
0.52
Depreciation
-
3.12
3.00
3.40
2.99
2.83
PBT
-
15.89
16.20
16.49
13.93
8.45
Tax
-
5.34
5.75
5.88
4.61
2.79
Tax Rate
-
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
-
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
-
10.53
10.36
9.76
9.32
5.66
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
-
1.64%
6.15%
4.72%
64.66%
 
Unadjusted EPS
-
0.14
0.13
0.13
0.12
2.54

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
117.35
108.70
100.22
95.20
87.71
Share Capital
78.07
78.07
78.07
78.07
22.30
Total Reserves
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
Current Liabilities
58.84
65.69
36.66
41.62
28.50
Trade Payables
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
8.27
9.46
9.04
8.11
5.30
Total Liabilities
183.92
180.66
142.50
143.63
124.49
Net Block
55.04
45.85
45.78
50.26
50.47
Gross Block
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
36.94
36.56
34.65
26.93
23.93
Non Current Assets
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
0.25
4.72
0.00
0.00
0.00
Non Current Investment
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
86.54
91.66
83.59
78.09
61.99
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
45.99
46.00
31.16
29.42
28.94
Cash & Bank
6.52
5.69
6.77
5.28
3.76
Other Current Assets
24.02
8.41
9.25
5.87
23.22
Short Term Loans & Adv.
13.52
16.10
25.47
27.63
17.28
Net Current Assets
27.70
25.98
46.93
36.47
33.49
Total Assets
183.92
180.65
142.50
143.63
124.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
13.84
24.07
0.08
6.73
5.78
PBT
15.88
16.10
16.49
13.93
8.45
Adjustment
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-5.10
-6.70
-3.25
-2.78
Net Investments
-7.49
-16.99
2.83
-2.57
Others
-5.09
0.95
1.16
1.07
Cash from Financing Activity
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Standalone /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
1.50
1.39
1.28
1.22
1.12
ROA
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
2.12
2.28
2.20
2.00
1.55
Receivable days
90.83
75.88
63.71
70.22
91.86
Inventory Days
25.15
25.97
21.92
19.22
19.28
Payable days
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.11
0.05
0.06
0.03
0.02
Interest Cover
48.48
119.10
54.58
30.75
17.10

Top Investors:

News Update:


  • Syncom Formulations - Quarterly Results
    14th Aug 2018, 19:54 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.